samedan logo
 
 
 
spacer
home > pmps > winter 2001 > pharmaceutical supply chains - the developing role of it
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Pharmaceutical Supply Chains - The Developing Role of IT

In the constantly changing environment of pharmaceutical supply and value chains, what must we now demand of the supporting IT systems and IT departments in order to ensure their validity, focus and ability to realise their value-adding potential?

To analyse and understand this question, we must first look at the changing nature of the industry over recent years. We need to understand how supply chain services - such as primary and secondary procurement for manufacturing and proactive utilisation of information transferred to and from sales and marketing functions - have evolved. We can then look at the potential for pharmaceutical supply chain development in the future, particularly with the advent of collaborative commerce initiatives.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Ray Dales and Melvyn Barnes of SchlumbergerSema Ray Dales is a Manufacturing and Supply Chain Professional with over 14 years' experience in the pharmaceutical industry. For the last six years, he has provided consultancy services to manufacturing industries, specifically in the areas of process improvement, the management of change, and supply chain development, particularly the opportunities offered by e-business initiatives.
Melvyn Barnes is an IT Professional and has been a Consultant with SchlumbergerSema for three years, specialising in the design, development and introduction of innovative IT strategies. He has over 25 years' experience of systems integration and IS strategy in the batch process manufacturing and pharmaceutical industries.

spacer
Ray Dales
spacer
spacer
spacer
Melvyn Barnes
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

SHIONOGI LAUNCHES FETCROJAŽ (CEFIDEROCOL) IN THE UNITED KINGDOM FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH LIMITED TREATMENT OPTIONS


More info >>

White Papers

The Emerging Use of Social Media in Orphan Disease Drug Research

Worldwide Clinical Trials Ltd

The use of various social media platforms, such as Twitter, Instagram, Facebook, and LinkedIn, for dissemination of clinical trial information has created a cornucopia of possibilities enabling clinical trial performance. Characterized by a people-to-people immediacy, social media permits extraordinarily adaptive modification of study information in real-time, and it does so in a highly targeted fashion.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement